Related Experiment Video
Updated: May 11, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Using higher doses to compensate for tubing residuals in extended-infusion piperacillin-tazobactam
Wendy J Lam1, Tanaya Bhowmick, Alan Gross
1Rutgers University Ernest Mario School of Pharmacy, Piscataway, NJ, USA. Wendy.Jung@gmail.com
Objective:
To mathematically assess drug losses due to infusion line residuals and evaluate methods to compensate for drug loss due to residual volumes in intravenous pump tubing.
Data Sources:
Literature was accessed through Ovid MEDLINE (1996-February 2013), using combinations of the search terms tubing residuals, residual volume, residual medication, intravenous infusions, intravenous injections, piperacillin, piperacillin-tazobactam, β-lactams, equipment design, infusion pumps, extended infusion, extended administration, and prolonged infusion. In addition, select reference citations from publications identified were reviewed.
Study Selection And Data Extraction:
All articles that involved extended-infusion piperacillin-tazobactam implementation strategies were included in the review.
Data Synthesis:
Infusion pump characteristics and tubing residuals can affect extended-infusion piperacillin-tazobactam dosing strategies. Two studies addressing tubing residuals were identified. Both studies recommended increasing infusion volumes to compensate for tubing residuals. One study also recommended decreasing infusion-line dead space by using alternative infusion pump systems. Study calculations suggest that higher doses of piperacillin-tazobactam may be used to account for medication left in tubing residuals if alternative infusion pump systems cannot be obtained, and increased infusion volumes are not an option.
Conclusions:
Extended-infusion piperacillin-tazobactam has been used as a method of maximizing pharmacodynamic target attainment. Use of higher doses of piperacillin-tazobactam may be a reasonable method to compensate for drug loss due to residual volumes in large-bore intravenous pump tubing.
Insights
Drug losses from intravenous pump tubing residuals can be compensated by increasing infusion volumes or using higher doses of piperacillin-tazobactam (PT). Adjusting PT dosing ensures effective treatment despite residual medication in infusion lines.
Area of Science:
- Pharmacology
- Pharmaceutical Technology
- Clinical Pharmacy
Background:
- Intravenous (IV) infusion lines retain residual drug volumes after administration.
- This residual volume can lead to sub-therapeutic dosing, particularly with extended-infusion regimens.
- Optimizing drug delivery is crucial for maximizing therapeutic efficacy.
Purpose of the Study:
- To mathematically assess drug losses in IV infusion lines.
- To evaluate methods for compensating drug loss due to residual volumes in IV pump tubing.
- To inform dosing strategies for extended-infusion piperacillin-tazobactam.
Main Methods:
- A literature review was conducted using Ovid MEDLINE and reference citations.
- Search terms included tubing residuals, residual volume, piperacillin-tazobactam, and infusion pumps.
- Studies focusing on extended-infusion piperacillin-tazobactam implementation were included.
Main Results:
- Two studies addressed tubing residuals, both recommending increased infusion volumes.
- One study suggested reducing infusion line dead space with alternative pump systems.
- Calculations indicated higher piperacillin-tazobactam doses can compensate for tubing residuals.
Conclusions:
- Extended-infusion piperacillin-tazobactam aims to maximize pharmacodynamic target attainment.
- Higher piperacillin-tazobactam doses are a viable strategy to offset drug loss in IV pump tubing.
- This approach ensures adequate drug delivery despite residual volumes.
Related Concept Videos
Drug Accumulation During Multiple Dosing: Intermittent IV Infusions
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
IV Infusion to Oral Dosing: Conversion Methods
Drug Accumulation During Multiple Dosing: Repetitive IV Injections
Drug Dosing in Renal Diseases: Dose Adjustments Based on Drug Clearance and Elimination Rate Constant
Dosage Interval and Administration Route: Determination Methods
